We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche Says Mircera Filing in U.S. and EU Proceeding as Planned
Roche Says Mircera Filing in U.S. and EU Proceeding as Planned
April 25, 2007
Roche's pending applications for investigational erythropoiesis-stimulating agent (ESA) Mircera in the U.S. and Europe are proceeding according to plan, William Burns, CEO of Roche's pharma division, said.